- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04348812
Transcranial Direct Current Stimulation (tDCS) Augments the Effects of Gamified, Mobile Attention Bias Modification
April 15, 2020 updated by: Tracy Dennis, Hunter College of City University of New York
The present study tested whether transcranial direct current stimulation (tDCS) across the prefrontal cortex (PFC), versus sham stimulation, effectively augments the beneficial effects of a gamified attention bias modification training (ABMT) mobile app.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Anxiety-related attentional bias (AB) is the preferential processing of threat observed in clinical and sub-clinical anxiety.
Attention bias modification training (ABMT) is a computerized cognitive training technique designed to systematically direct attention away from threat and ameliorate AB, but mixed and null findings have highlighted gaps in our understanding of mechanisms underlying ABMT and how to design the most effective delivery systems.
One neuromodulation technique, transcranial direct current stimulation (tDCS) across the prefrontal cortex (PFC) may augment the effects of ABMT by strengthening top-down cognitive control processes, but the evidence base is limited and has not been generalized to current approaches in digital therapeutics, such as mobile applications.
The present study tested whether tDCS across the PFC, versus sham stimulation, effectively augments the beneficial effects of a gamified ABMT mobile app.
Thirty-eight adults (Mage = 23.92,
SD = 4.75; 18 females) evidencing low-to-moderate anxiety symptoms were randomly assigned to active or sham tDCS for 30-minutes while receiving ABMT via a mobile app.
Participants reported on potential moderators of ABMT, including life stress and trait anxiety.
ECG was recorded during a subsequent stressor to generate respiratory sinus arrhythmia (RSA) suppression as a metric of stress resilience.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Hunter College of The City University of New York
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- mild - moderate anxiety
Exclusion Criteria:
- psychotic disorder
- substance use disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: tDCS Active
Transcranial direct current stimulation with ABMT
|
mobile attention bias modification training for anxiety, using the app Personal Zen
Other Names:
Soterix 1X1 tDCS Limited Total Energy (LTE) Stimulator
Other Names:
|
SHAM_COMPARATOR: tDCS sham
Transcranial direct current sham stimulation with ABMT
|
mobile attention bias modification training for anxiety, using the app Personal Zen
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported negative mood symptoms
Time Frame: Day 1
|
Self report using the Depression, Anxiety, Stress Scale (DASS); Higher scores mean more severe negative mood/worse outcomes (scores ranging from 0-42)
|
Day 1
|
Self-reported subjective state anxiety
Time Frame: Day 1
|
Self report of state anxiety using the State-Trait Anxiety Inventory (STAI); Higher scores mean greater anxiety severity/worse outcomes (scores ranging from 20-80).
|
Day 1
|
Threat bias, or dsyregulated attention towards threat, measured via computer assay
Time Frame: Day 1
|
Using the computerized, reaction time-based cognitive assessment task, the "dot probe", biased attention towards or away from threat-relevant information will be assessed based on reaction-time based scoring procedures.
Higher scores mean greater bias/worse outcomes
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Magnitude of respiratory sinus arrhythmia, or variability in heart rate due to respiration rate
Time Frame: Day 1
|
Respiratory sinus arrhythmia (RSA), calculated using mobile electrocardiogram, will be assessed during the Trier Social Stress Task, a standardized behavioral assessment of stress.
Higher scores mean greater contribution of respiratory rate to heart rate.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Tracy Dennis, PhD, Hunter College, CUNY
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2019
Primary Completion (ACTUAL)
December 15, 2019
Study Completion (ACTUAL)
December 15, 2019
Study Registration Dates
First Submitted
April 12, 2020
First Submitted That Met QC Criteria
April 14, 2020
First Posted (ACTUAL)
April 16, 2020
Study Record Updates
Last Update Posted (ACTUAL)
April 17, 2020
Last Update Submitted That Met QC Criteria
April 15, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 334490
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown
Clinical Trials on ABMT
-
Hunan Normal UniversityCompletedDepressive DisorderChina
-
Tel Aviv UniversityCompletedAnxiety DisordersIsrael
-
Hunan Normal UniversityCompletedMajor Depressive Disorder, Single Episode, UnspecifiedChina
-
Erasmus Medical CenterTerminatedGeneralized Anxiety Disorder | Social Anxiety Disorder | Specific Phobia | Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood, Early OnsetNetherlands
-
University College DublinTel Aviv UniversityCompletedDepression | Anxiety
-
Research Foundation for Mental Hygiene, Inc.Completed
-
NYU Langone HealthCompletedPediatric Multiple SclerosisUnited States
-
Yair Bar-HaimGeha Mental Health CenterCompleted
-
Tel Aviv UniversityCompletedGeneralized Anxiety Disorder | Social Anxiety DisorderIsrael
-
Hunan Normal UniversityUnknownDepressive SymptomsChina